Beamtree Holdings Limited (ASX:BMT)

CTI BioPharma Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	76	66	63	72	95	32
Market Cap Growth	18.35%	6.27%	-13.20%	-23.90%	198.81%	37.65%
Enterprise Value	72	61	57	66	91	28
Last Close Price	0.26	0.23	0.23	0.29	0.42	0.17
PE Ratio	-	-	-	-	-	82.74
Forward PE	-	24.85	24.85	24.85	24.85	10.12
PS Ratio	2.62	2.41	2.75	4.35	11.29	7.68
PB Ratio	1.71	1.41	1.32	1.48	2.25	1.08
P/TBV Ratio	79.10	27.07	40.61	67.02	6.30	10.12
P/FCF Ratio	46.43	-	96.07	-	-	30.88
P/OCF Ratio	42.44	-	81.44	-	394.47	30.27
EV/Sales Ratio	2.50	2.22	2.52	3.98	10.85	6.67
EV/EBITDA Ratio	-	-	-	-	-	128.92
EV/EBIT Ratio	-	-	-	-	-	145.23
EV/FCF Ratio	44.38	-	88.00	-	-	26.81
Debt / Equity Ratio	0.04	0.04	0.02	0.02	0.02	0.00
Debt / EBITDA Ratio	-	-	-	-	-	0.10
Debt / FCF Ratio	0.96	-	1.16	-	-	0.04
Asset Turnover	0.50	0.45	0.36	0.30	0.21	0.15
Quick Ratio	1.12	1.28	1.18	1.49	4.62	1.98
Current Ratio	1.12	1.28	1.18	1.49	4.62	1.98
Return on Equity (ROE)	-11.79%	-10.82%	-14.42%	-9.81%	-1.08%	1.55%
Return on Assets (ROA)	-6.03%	-6.46%	-6.65%	-9.51%	-0.75%	0.44%
Return on Capital (ROIC)	-7.33%	-8.16%	-8.61%	-11.40%	-0.83%	0.48%
Return on Capital Employed (ROCE)	-	-	-	-	-	0.60%
Earnings Yield	-7.21%	-7.68%	-11.04%	-6.17%	-0.41%	1.21%
FCF Yield	2.15%	-0.84%	1.04%	-3.30%	-0.38%	3.24%
Buyback Yield / Dilution	-10.14%	-14.19%	-2.65%	-20.91%	-36.02%	-690.66%

Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.